TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18799202

Group type: EXPERIMENTAL
Intervention: Tamsulosin, 0.4 mg/d
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control (no tamsulosin)
Number of subjects: 139
Study: 15817343

Group type: EXPERIMENTAL
Intervention: Pilocarpine (n = 65)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (n = 65)
Number of subjects: 130
Study: 14512671

Group type: EXPERIMENTAL
Intervention: Intense endurance training
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 27
Study: 10649929

Group type: EXPERIMENTAL
Intervention: Gluma Alternate
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi-Purpose (SMP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Health-Dent Desensitizer
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer (rescue treatment)
Number of subjects: 55
Study: 8727805

Group type: EXPERIMENTAL
Intervention: Mitomycin
Number of subjects: 469

Group type: COMPARATOR
Intervention: BCG-Tice
Number of subjects: 469

Group type: COMPARATOR
Intervention: BCG-RIVM
Number of subjects: 469
Study: 1829030

Group type: EXPERIMENTAL
Intervention: gestodene (75 micrograms) + ethinyl oestradiol (30 micrograms)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: desogestrel (150 micrograms) + ethinyl oestradiol (30 micrograms)
Number of subjects: 20
Study: 6852987

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol 200 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Atenolol 25 mg
Number of subjects: 10
Study: 30614168

Group type: EXPERIMENTAL
Intervention: AH-plus with continuous wave of condensation technique (CTW)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: EndoSeal MTA with single-cone technique (SCT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: MTA Fillapex with single-cone technique (SCT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: EndoSequence BC Sealer with single-cone technique (SCT)
Number of subjects: 43
Study: 27957678

Group type: EXPERIMENTAL
Intervention: RPI25 (25% replacement of SPI)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: RPI50 (50% replacement of SPI)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: RPI75 (75% replacement of SPI)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: RPI100 (100% replacement of SPI)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (Soybean protein isolate)
Number of subjects: 180
Study: 25194621

Group type: EXPERIMENTAL
Intervention: Chair stand exercise (12 weeks, 3 sessions/week)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control exercise (stretch, 1 session/week)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Chair stand exercise
Number of subjects: 27
Study: 24651278

Group type: EXPERIMENTAL
Intervention: 33 °C for 24 hours
Number of subjects: 939

Group type: COMPARATOR
Intervention: 36 °C for 24 hours
Number of subjects: 939
Study: 23072081

Group type: EXPERIMENTAL
Intervention: Acupuncture and Tuina therapy (group A)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Calcium Carbonate D3 (group B)
Number of subjects: 64
Study: 19775918

Group type: EXPERIMENTAL
Intervention: Anaconda AAA Stent Graft System
Number of subjects: 61
Study: 17880325

Group type: EXPERIMENTAL
Intervention: NSTE ACS patients
Number of subjects: 26466

Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 26466

Group type: EXPERIMENTAL
Intervention: Medium-risk group
Number of subjects: 26466

Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 26466
Study: 15291377

Group type: EXPERIMENTAL
Intervention: Olmesartan (2.5-80 mg once daily)
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Olmesartan (with or without hydrochlorothiazide)
Number of subjects: 792

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study: 11939868

Group type: EXPERIMENTAL
Intervention: Planned cesarean delivery
Number of subjects: 1596

Group type: COMPARATOR
Intervention: Planned vaginal delivery
Number of subjects: 1596
Study: 9443715

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 7621039

Group type: EXPERIMENTAL
Intervention: Electronic thermography
Number of subjects: 44
Study: 2006597

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ketobemidone
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All groups (morphine, meperidine, ketobemidone)
Number of subjects: 81
Study: 6754485

Group type: EXPERIMENTAL
Intervention: khellin, orally administered for 4 months with subsequent exposure to natural sunlight
Number of subjects: 30

Group type: COMPARATOR
Intervention: control group (30 subjects)
Number of subjects: 30
Study: 31597484

Group type: EXPERIMENTAL
Intervention: Watermelon juice
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sugar water
Number of subjects: 27

Group type: COMPARATOR
Intervention: Gatorade
Number of subjects: 27

Group type: COMPARATOR
Intervention: Water
Number of subjects: 27
Study: 31184382

Group type: EXPERIMENTAL
Intervention: Behavioral intervention delivered by pediatricians or psychologists (n=183)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Usual care (n=178)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 361
Study: 28923880

Group type: EXPERIMENTAL
Intervention: High sugar diet (26% total energy)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Low sugar diet (6% total energy)
Number of subjects: 25
Study: 25730895

Group type: EXPERIMENTAL
Intervention: Action planning intervention for engaging in physical activity
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Action planning intervention for limiting or interrupting sedentary behavior
Number of subjects: 195
Study: 24996973

Group type: EXPERIMENTAL
Intervention: Robot brushing simulation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Clinical brushing techniques (horizontal, rotating, vertical)
Number of subjects: 27
Study: 22430972

Group type: EXPERIMENTAL
Intervention: Entecavir plus adefovir (ETV+ADV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lamivudine plus adefovir (LAM+ADV)
Number of subjects: 90
Study: 19492933

Group type: EXPERIMENTAL
Intervention: Hypocaloric nasogastric feeds within 48 h of intubation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intravenous fluids
Number of subjects: 59
Study: 17454965

Group type: EXPERIMENTAL
Intervention: Implicit measure of loneliness
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Functional support indices of social support
Number of subjects: 25

Group type: COMPARATOR
Intervention: Structural support
Number of subjects: 25
Study: 15206964

Group type: EXPERIMENTAL
Intervention: Ligasure haemorrhoidectomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Open haemorrhoidectomy
Number of subjects: 30
Study: 12150168

Group type: EXPERIMENTAL
Intervention: Heptavalent pneumococcal conjugate vaccine
Number of subjects: 36471

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36471
Study: 9718904

Group type: EXPERIMENTAL
Intervention: Rice-starch ORS
Number of subjects: 63

Group type: COMPARATOR
Intervention: Glucose-based ORS
Number of subjects: 63
Study: 7806421

Group type: EXPERIMENTAL
Intervention: High volume plasmapheresis
Number of subjects: 18
Study: 2503865

Group type: EXPERIMENTAL
Intervention: Enteral glucose by nasojejunal tube
Number of subjects: 20

Group type: COMPARATOR
Intervention: Parenteral glucose by intravenous infusion
Number of subjects: 20
Study: 339865

Group type: EXPERIMENTAL
Intervention: Ticrynafen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 12
Study: 30900550

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including a webinar, monthly reports of general practice-specific data for antibiotic prescribing, and decision support tools.
Number of subjects: 582675

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 582675

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for adults aged 15-84 years.
Number of subjects: 582675

Group type: EXPERIMENTAL
Intervention: Safety outcomes analysis from trial data.
Number of subjects: 582675

Group type: COMPARATOR
Intervention: Cohort study in non-trial practices.
Number of subjects: 582675
Study: 27577608

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBT) training, six two-hour sessions for three weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study: 25826620

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Cognitive activity
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Integrated cognitive and physical exercise (CP)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Social activity (active control)
Number of subjects: 555
Study: 23975232

Group type: EXPERIMENTAL
Intervention: Instruction to walk 'as fast as possible'
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard instruction to walk 'as far as possible'
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Instruction to walk 'at your normal pace'
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Instruction to walk 'at a leisurely pace'
Number of subjects: 24
Study: 21392622

Group type: EXPERIMENTAL
Intervention: Idebenone (450/900 mg/d or 1,350/2,250 mg/d)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 18835608

Group type: EXPERIMENTAL
Intervention: Capnometry-assisted breathing training targeting respiratory dysregulation
Number of subjects: 35
Study: 17854242

Group type: EXPERIMENTAL
Intervention: Risperidone (2 mg with dinner)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quetiapine (100 mg with dinner and 100 mg with breakfast)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 30
Study: 15497673

Group type: EXPERIMENTAL
Intervention: 750 mg sultamicillin tablets (Duobaktam 750 mg tablets)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 250 mg/5mL sultamicillin suspension (Duobaktam 250 mg/5mL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Secondary parameter tmax
Number of subjects: 24
Study: 11403756

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 9399753

Group type: EXPERIMENTAL
Intervention: Methotrexate (12.5 mg weekly)
Number of subjects: 84

Group type: COMPARATOR
Intervention: 6-mercaptopurine (50 mg daily)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 7954556

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ramipril (5 mg)
Number of subjects: 20
Study: 3665340

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (not receiving anticonvulsant therapy)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Oral administration of prednisone and methylprednisolone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Discontinuation of anticonvulsant therapy
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination anticonvulsant therapy
Number of subjects: 15
Study: 29494398

Group type: EXPERIMENTAL
Intervention: RANK expression in parotid gland carcinomas
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: RANKL expression in parotid gland carcinomas
Number of subjects: 46

Group type: COMPARATOR
Intervention: RANK expression in parotid gland adenomas
Number of subjects: 46

Group type: COMPARATOR
Intervention: RANKL expression in parotid gland adenomas
Number of subjects: 46

Group type: COMPARATOR
Intervention: Comparison of RANK/RANKL expression between carcinomas and adenomas
Number of subjects: 46
Study: 27410242

Group type: EXPERIMENTAL
Intervention: One valid cue
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Two valid cues
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Three valid cues
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All valid cues
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Younger participants
Number of subjects: 240
Study: 24622830

Group type: EXPERIMENTAL
Intervention: Beer (4.7% vol, 400 ml)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Red wine (13.7% vol, 200 ml)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Whisky (43.5% vol, 100 ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isotonic glucose solution
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethanol solutions of identical proof
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High proof ethanol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Red wine and whisky
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control ethanol solutions
Number of subjects: 12
Study: 23482332

Group type: EXPERIMENTAL
Intervention: Internal motivation (patient-oriented brochure)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: External motivation (physician letter of recommendation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (generic referral card)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Internal motivation
Number of subjects: 50
Study: 21538388

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18364344

Group type: EXPERIMENTAL
Intervention: Web-based self-help intervention
Number of subjects: 213

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 213
Study: 16311751

Group type: EXPERIMENTAL
Intervention: Biopsychosocial therapy (BT; n=31)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional biomedical therapy (MT; n=33)
Number of subjects: 64
Study: 12747192

Group type: EXPERIMENTAL
Intervention: Kang Wei Granules
Number of subjects: 288

Group type: COMPARATOR
Intervention: De Nol triple therapy
Number of subjects: 288
Study: 10802993

Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 8607332

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy (oral anticoagulants replaced with heparin from 6 to 12 weeks, vitamin K antagonists during second and third trimesters, heparin after 36 weeks until 10 days postpartum)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified, but implied to be those not receiving anticoagulant therapy)
Number of subjects: 54
Study: 1592844

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 3894257

Group type: EXPERIMENTAL
Intervention: tiaprofenic acid 600 mg daily
Number of subjects: 68

Group type: COMPARATOR
Intervention: indomethacin 75 mg daily
Number of subjects: 68
Study: 31451342

Group type: EXPERIMENTAL
Intervention: arthrocentesis plus HA (group Ia)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: single HA (group Ib)
Number of subjects: 90

Group type: COMPARATOR
Intervention: control (group Ic)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: arthrocentesis plus HA (group IIa)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: single HA (group IIb)
Number of subjects: 90

Group type: COMPARATOR
Intervention: control (group IIc)
Number of subjects: 90
Study: 29854436

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 26409247

Group type: EXPERIMENTAL
Intervention: Free pregnancy test kits provided to CHWs (treatment group)
Number of subjects: 622

Group type: COMPARATOR
Intervention: No pregnancy test kits provided to CHWs (control group)
Number of subjects: 622
Study: 24628950

Group type: EXPERIMENTAL
Intervention: Hyperthermic intraperitoneal chemotherapy with oxaliplatin
Number of subjects: 306

Group type: COMPARATOR
Intervention: Perioperative systemic chemotherapy and D1-D2 curative gastrectomy
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Ancillary study comparing incidence of positive peritoneal cytology pre- and post-gastrectomy
Number of subjects: 306
Study: 22814006

Group type: EXPERIMENTAL
Intervention: Perazine
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 191
Study: 21224795

Group type: EXPERIMENTAL
Intervention: Fast track management (whole)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fast track management (partial)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fast track management (postoperative only)
Number of subjects: 75
Study: 18278775

Group type: EXPERIMENTAL
Intervention: EVLA 1 (stepwise laser withdrawal)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: EVLA 2 (continuous laser withdrawal)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Surgery (saphenofemoral ligation, GSV stripping, multiple phlebectomies)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: EVLA 1
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: EVLA 2
Number of subjects: 101

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: EVLA (both methods)
Number of subjects: 101
Study: 15608044

Group type: COMPARATOR
Intervention: Control group (group L, n=21) received i.v. saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Perineural tramadol group (group T, n=20) received i.v. saline and PCB with tramadol 1.5 mg kg(‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Systemic tramadol group (group IT, n=19) received i.v. tramadol 1.5 mg kg(‐1)
Number of subjects: 60
Study: 11854391

Group type: EXPERIMENTAL
Intervention: Cisplatin plus vinorelbine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carboplatin plus paclitaxel
Number of subjects: 0
Study: 10354830

Group type: EXPERIMENTAL
Intervention: Operative removal of high-grade carotid stenoses
Number of subjects: 250000

Group type: EXPERIMENTAL
Intervention: Carotid thrombarterectomy (TEA)
Number of subjects: 250000

Group type: COMPARATOR
Intervention: Interventional methods (stent, PTA)
Number of subjects: 250000
Study: 8530798

Group type: EXPERIMENTAL
Intervention: Nontapering course of prednisone
Number of subjects: 76

Group type: COMPARATOR
Intervention: Tapering course of prednisone (historical control)
Number of subjects: 76
Study: 2121653

Group type: EXPERIMENTAL
Intervention: Warm-up (WU trial) consisting of a 400‐m front crawl swim (82% VO2max), 400‐m flutter kicking (45% VO2max), and 4 x 50‐m front crawl sprints (111% VO2max)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Warm-up (WU trial)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No warm-up (NWU trial)
Number of subjects: 8
Study: 675854

Group type: EXPERIMENTAL
Intervention: Conventional radical or extended radical mastectomy
Number of subjects: 716
Study: 28704841

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 3114

Group type: EXPERIMENTAL
Intervention: BMI ≥ 35 kg m-2
Number of subjects: 3114

Group type: COMPARATOR
Intervention: Physical activity in the third quartile
Number of subjects: 3114

Group type: EXPERIMENTAL
Intervention: Smoking, high BMI, and high alcohol consumption
Number of subjects: 3114
Study: 25993883

Group type: EXPERIMENTAL
Intervention: Creatine before resistance training (CR-B)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Creatine after resistance training (CR-A)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (both CR-B and CR-A)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 39
Study: 23117723

Group type: EXPERIMENTAL
Intervention: Extended-duration enoxaparin prophylaxis (40 mg daily for 28±4 days)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study: 21797984

Group type: EXPERIMENTAL
Intervention: Trocar-guided mesh insertion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Native tissue repair
Number of subjects: 60
Study: 19558471

Group type: EXPERIMENTAL
Intervention: RAPD method using CA1 primer
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: RAPD method using CA2 primer
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: RAPD method using both CA1 and CA2 primers
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: CHEF karyotyping
Number of subjects: 57
Study: 17034954

Group type: EXPERIMENTAL
Intervention: Oral progesterone (400mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 14523053

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg q.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg q.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atorvastatin and Fenofibrate
Number of subjects: 8
Study: 11215603

Group type: EXPERIMENTAL
Intervention: High Dk/t silicone hydrogel lenses (lotrafilcon A) worn for 30 nights
Number of subjects: 127

Group type: COMPARATOR
Intervention: Low Dk/t HEMA-based lenses (etafilcon A) worn for 6 nights
Number of subjects: 127
Study: 9517650

Group type: EXPERIMENTAL
Intervention: Early feeding (group A) at 4 hours after PEG placement
Number of subjects: 112

Group type: COMPARATOR
Intervention: Delayed feeding (group B) at 24 hours after PEG placement
Number of subjects: 112
Study: 11271244

Group type: EXPERIMENTAL
Intervention: Acyclovir (3200 mg/day if creatinine clearance > 50 ml/min, intravenously for first 90 days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: No prophylaxis (Control group)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 37
Study: 3051990

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 to 180 mg twice daily)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Captopril (25 to 75 mg twice daily)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Diltiazem and Captopril in combination
Number of subjects: 132
Study: 15177815

Group type: EXPERIMENTAL
Intervention: Neglect patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy and patient controls
Number of subjects: 0